ABSTRACT

INTRODUCTION Changes in blood coagulation and fibrinolysis during pregnancy create a state of hypercoagulability.1,2 This phenomenon, probably caused by hormonal changes, protects the woman from fatal haemorrhage during delivery but predisposes her to thromboembolism. There are significant data suggesting that oestradiolinduced triglyceride alteration is responsible for these changes in coagulation and fibrinolysis.3